Timothy SullivanBPX-501 — Value Proposition ExplainedRisk / Reward is Widely MisunderstoodMar 3, 20161Mar 3, 20161
Timothy SullivanBellicum: Data From ASH 2015, Orphan Disease Focus & Sizing the BPX-501 MarketDisclosure: The fund I work for, Aju IB Investment, was a private investor in Bellicum before its IPO and invested further in the IPO. The…Dec 6, 20151Dec 6, 20151
Timothy SullivanThe Bellicum Story: What you Need to Know Going Into ASH 2015Bellicum is an Exciting Story Heading into ASH 2015 and BeyondDec 3, 2015Dec 3, 2015